Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Treatment With a Scheme With Low Doses of Bortezomib / Melphalan / Prednisone (MPV) in Patients With Multiple Myeloma (Velcadito)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02773550
Recruitment Status : Terminated (Low recruiment.)
First Posted : May 16, 2016
Last Update Posted : January 18, 2020
Sponsor:
Information provided by (Responsible Party):
Ernesto Perez Persona, Basque Health Service

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : July 2018
Actual Study Completion Date : July 2018